Cargando…
A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13
We developed a novel murine monoclonal antibody (mAb) against the C-terminal α-helix of the human von Willebrand factor A2, designated SZ-179. We showed that SZ-179 inhibited the interactions between VWF and ADAMTS13 and prevented the degradation of high molecular weight VWF multimers. Importantly,...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292787/ https://www.ncbi.nlm.nih.gov/pubmed/28166803 http://dx.doi.org/10.1186/s13045-017-0407-1 |
_version_ | 1782504989967515648 |
---|---|
author | Zhang, Lulu Su, Jian Shen, Fei Ma, Zhenni Zhao, Yiming Xia, Lijun Ruan, Changgeng |
author_facet | Zhang, Lulu Su, Jian Shen, Fei Ma, Zhenni Zhao, Yiming Xia, Lijun Ruan, Changgeng |
author_sort | Zhang, Lulu |
collection | PubMed |
description | We developed a novel murine monoclonal antibody (mAb) against the C-terminal α-helix of the human von Willebrand factor A2, designated SZ-179. We showed that SZ-179 inhibited the interactions between VWF and ADAMTS13 and prevented the degradation of high molecular weight VWF multimers. Importantly, SZ-179 reduced the proteolysis of VWF-R1597W mutant by rADAMTS13 dose-dependently under native conditions. Our findings reveal a potential therapeutic target for bleeding disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0407-1) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5292787 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-52927872017-02-10 A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 Zhang, Lulu Su, Jian Shen, Fei Ma, Zhenni Zhao, Yiming Xia, Lijun Ruan, Changgeng J Hematol Oncol Letter to the Editor We developed a novel murine monoclonal antibody (mAb) against the C-terminal α-helix of the human von Willebrand factor A2, designated SZ-179. We showed that SZ-179 inhibited the interactions between VWF and ADAMTS13 and prevented the degradation of high molecular weight VWF multimers. Importantly, SZ-179 reduced the proteolysis of VWF-R1597W mutant by rADAMTS13 dose-dependently under native conditions. Our findings reveal a potential therapeutic target for bleeding disorders. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s13045-017-0407-1) contains supplementary material, which is available to authorized users. BioMed Central 2017-02-06 /pmc/articles/PMC5292787/ /pubmed/28166803 http://dx.doi.org/10.1186/s13045-017-0407-1 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Letter to the Editor Zhang, Lulu Su, Jian Shen, Fei Ma, Zhenni Zhao, Yiming Xia, Lijun Ruan, Changgeng A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title | A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title_full | A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title_fullStr | A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title_full_unstemmed | A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title_short | A novel monoclonal antibody against the von Willebrand Factor A2 domain reduces its cleavage by ADAMTS13 |
title_sort | novel monoclonal antibody against the von willebrand factor a2 domain reduces its cleavage by adamts13 |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292787/ https://www.ncbi.nlm.nih.gov/pubmed/28166803 http://dx.doi.org/10.1186/s13045-017-0407-1 |
work_keys_str_mv | AT zhanglulu anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT sujian anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT shenfei anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT mazhenni anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT zhaoyiming anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT xialijun anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT ruanchanggeng anovelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT zhanglulu novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT sujian novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT shenfei novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT mazhenni novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT zhaoyiming novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT xialijun novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 AT ruanchanggeng novelmonoclonalantibodyagainstthevonwillebrandfactora2domainreducesitscleavagebyadamts13 |